Sotera Health Company (Nasdaq: SHC), a top global provider of essential sterilization solutions, lab testing, and advisory services for the healthcare sector, has announced that it will be releasing its financial results for the first quarter of 2024 on Thursday, May 2, 2024. The results will be shared before the market opens on that day, and a conference call will be held at 9:00 a.m. Eastern Time to discuss the Company’s performance and financial status.
To join the live call, participants can dial 1-844-481-2916 within the United States or 1-412-317-0709 from other locations. Additionally, a live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will also be available later in the day on May 2nd.
Investors can find updates on recent developments concerning the Company on the Investor Relations section of Sotera Health’s website at Investor Relations | Sotera Health. For updates specifically related to Ethylene Oxide, information can be found at Ethylene Oxide | Sotera Health.
Sotera Health Company is dedicated to providing mission-critical end-to-end sterilization solutions, lab testing, and advisory services to support the healthcare industry. The Company operates through three businesses – Sterigenics®, Nordion®, and Nelson Labs® – all committed to the mission of Safeguarding Global Health®. Each business offers unique products and services that help healthcare professionals provide better care to patients around the world.
For any inquiries related to financial reporting or investor relations matters, individuals can reach out to Jason Peterson, Vice President & Treasurer at Sotera Health through IR@soterahealth.com or Kristin Gibbs, Chief Marketing Officer at Sotera Health via kgibbs@soterahealth.com. Additional details about Sotera Health Company can be sourced from their official website (SoteraHealthCompany).
